Johnson & Johnson To Begin Human Testing Of COVID Vaccine In September
#Socialites, get into this! Earlier this Monday morning, Johnson & Johnson announced that it has made progress on a vaccine they’ve been working on to prevent COVID-19 and apparently, the product could be ready in early 2021.
RELATED: FDA Authorizes COVID-19 Test That Produces Results In Less Than 15 Minutes
The company also shared that it has committed over $1 billion of investment in partnership with the federal Biomedical Advanced Research and Development Authority, which is part of the Department of Health and Human Services, to co-fund vaccine research, CNBC notes. J&J’s lead vaccine candidate will start a phase 1 human clinical study by September. Clinical data on its effects is expected before the end of the year. Now, if the vaccine works out right, the company said the product could be available for emergency use early next year.
Johnson & Johnson is just one of many companies that are currently working on a vaccine for COVID-19, which has spread across the globe and has killed at least 34,686 worldwide, according to the news site.
“We have very good early indicators that not only can we depend on this to be a safe vaccine base but also one that will ultimately be effective based on all the early testing and modelling we’ve been doing,” Chairman and CEO Alex Gorsky said Monday on CNBC’s “Squawk Box.” “This is a bit of a moonshot for J&J going forward, but it’s one we feel is very, very important for use to be doing at this period in time.”
Press Play Below For More:
RELATED: More Than 500 NYPD Officers Have Tested Positive For COVID-19